Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosario Yerbes

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Investigational New Drugs|November 26, 2010
Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAILRosario Yerbes, Abelardo López-Rivas
Cancer Research|September 5, 2006
Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cellsCarmen Palacios, Rosario Yerbes, Abelardo López-Rivas
Biochimica Et Biophysica Acta|October 19, 2010
Cellular FLIP(L) plays a survival role and regulates morphogenesis in breast epithelial cellsRosario Yerbes, Carmen Palacios, Mauricio J Reginato, et al.
Cells|October 13, 2023
Role of the YAP/TAZ-TEAD Transcriptional Complex in the Metabolic Control of TRAIL Sensitivity by the Mevalonate Pathway in Cancer CellsYounes El Yousfi, Rocío Mora-Molina, Abelardo López-Rivas, et al.
Current Pharmaceutical Design|August 16, 2013
The long and winding road to cancer treatment: the TRAIL systemCarmen Palacios, Rosario Yerbes, Tania Sanchez-Perez, et al.
Cell Death & Disease|October 27, 2022
Limiting glutamine utilization activates a GCN2/TRAIL-R2/Caspase-8 apoptotic pathway in glutamine-addicted tumor cellsRosario Yerbes, Rocío Mora-Molina, F Javier Fernández-Farrán, et al.
Cell Research|May 7, 2008
Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanismGustavo Ortiz-Ferrón, Rosario Yerbes, Adriana Eramo, et al.
Oncotarget|December 8, 2017
Oncogenic p95HER2/611CTF primes human breast epithelial cells for metabolic stress-induced down-regulation of FLIP and activation of TRAIL-R/Caspase-8-dependent apoptosisRosa Martín-Pérez, Rosario Yerbes, Rocío Mora-Molina, et al.
Cancer Research|January 24, 2014
Activated ERBB2/HER2 licenses sensitivity to apoptosis upon endoplasmic reticulum stress through a PERK-dependent pathwayRosa Martín-Pérez, Carmen Palacios, Rosario Yerbes, et al.
Oncotarget|August 4, 2016
TAM receptors Tyro3 and Mer as novel targets in colorectal cancerRobin Schmitz, Aida Freire Valls, Rosario Yerbes, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Investigational New Drugs|November 26, 2010
Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAILRosario Yerbes, Abelardo López-Rivas
Cancer Research|September 5, 2006
Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cellsCarmen Palacios, Rosario Yerbes, Abelardo López-Rivas
Biochimica Et Biophysica Acta|October 19, 2010
Cellular FLIP(L) plays a survival role and regulates morphogenesis in breast epithelial cellsRosario Yerbes, Carmen Palacios, Mauricio J Reginato, et al.
Cells|October 13, 2023
Role of the YAP/TAZ-TEAD Transcriptional Complex in the Metabolic Control of TRAIL Sensitivity by the Mevalonate Pathway in Cancer CellsYounes El Yousfi, Rocío Mora-Molina, Abelardo López-Rivas, et al.
Current Pharmaceutical Design|August 16, 2013
The long and winding road to cancer treatment: the TRAIL systemCarmen Palacios, Rosario Yerbes, Tania Sanchez-Perez, et al.
Cell Death & Disease|October 27, 2022
Limiting glutamine utilization activates a GCN2/TRAIL-R2/Caspase-8 apoptotic pathway in glutamine-addicted tumor cellsRosario Yerbes, Rocío Mora-Molina, F Javier Fernández-Farrán, et al.
Cell Research|May 7, 2008
Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanismGustavo Ortiz-Ferrón, Rosario Yerbes, Adriana Eramo, et al.
Oncotarget|December 8, 2017
Oncogenic p95HER2/611CTF primes human breast epithelial cells for metabolic stress-induced down-regulation of FLIP and activation of TRAIL-R/Caspase-8-dependent apoptosisRosa Martín-Pérez, Rosario Yerbes, Rocío Mora-Molina, et al.
Cancer Research|January 24, 2014
Activated ERBB2/HER2 licenses sensitivity to apoptosis upon endoplasmic reticulum stress through a PERK-dependent pathwayRosa Martín-Pérez, Carmen Palacios, Rosario Yerbes, et al.
Oncotarget|August 4, 2016
TAM receptors Tyro3 and Mer as novel targets in colorectal cancerRobin Schmitz, Aida Freire Valls, Rosario Yerbes, et al.
Pageof 2